Scientists discover new drug for ovarian cancer at UNM center

ALBUQUERQUE (KRQE) – A group of scientists at the UNM Cancer Center have just discovered a new anti-inflammatory drug that acts against ovarian cancer.

The drug has already been approved and is proving to slow cancer growth and help women live longer after surgery. The drug, Ketorolac, ultimately helps control cellular growth and the spreading of active cancer cells.

The discovery of this drug could open up more opportunity in research of how to treat ovarian cancer. The scientists are planning a series of human clinical trials to better understand how Ketrolac works in women after ovarian cancer surgery.

Ovarian cancer has no symptoms. Often, it is discovered only after it has spread to other organs. Fewer than half of women diagnosed with ovarian cancer are still alive five years later.

KRQE.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Users who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s